These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14754709)

  • 41. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):315-326. PubMed ID: 27977304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of combination contraceptives on weight.
    Salisbury-Afshar E
    Am Fam Physician; 2012 Dec; 86(11):1009. PubMed ID: 23198667
    [No Abstract]   [Full Text] [Related]  

  • 43. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet H; Grimes D; Helmerhorst F; Schulz K
    Cochrane Database Syst Rev; 2001; (4):CD003283. PubMed ID: 11687185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus.
    Harvengt C
    Diabete Metab; 1992; 18(2):71-7. PubMed ID: 1511755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Weight gain due to hormonal contraception: myth or truth?].
    Häni D; Imthurn B; Merki-Feld GS
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):87-93. PubMed ID: 19346753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet HA; Grimes DA; Helmerhorst FM; Schulz KF
    Cochrane Database Syst Rev; 2003; (2):CD003283. PubMed ID: 12804457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.
    Culwell KR; Curtis KM; Del Carmen Cravioto M
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):341-353. PubMed ID: 19622996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormonal contraception and lactation.
    Kelsey JJ
    J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newer progestogens.
    Rowlands S
    J Fam Plann Reprod Health Care; 2003 Jan; 29(1):13-6. PubMed ID: 12626173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypertension and contraception].
    Perol S; Hugon-Rodin J; Plu-Bureau G
    Presse Med; 2019 Nov; 48(11 Pt 1):1269-1283. PubMed ID: 31757732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.
    Young EA; Kornstein SG; Harvey AT; Wisniewski SR; Barkin J; Fava M; Trivedi MH; Rush AJ
    Psychoneuroendocrinology; 2007 Aug; 32(7):843-53. PubMed ID: 17629629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contraceptive use among women with multiple sclerosis: a systematic review.
    Zapata LB; Oduyebo T; Whiteman MK; Houtchens MK; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):612-620. PubMed ID: 27452316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estetrol/drospirenone (Nextstellis) - a new combination oral contraceptive.
    Med Lett Drugs Ther; 2021 Jun; 63(1627):101-102. PubMed ID: 34181632
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
    de Wit AE; de Vries YA; de Boer MK; Scheper C; Fokkema A; Janssen CAH; Giltay EJ; Schoevers RA
    Am J Obstet Gynecol; 2021 Dec; 225(6):624-633. PubMed ID: 34224688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptives for functional ovarian cysts.
    Grimes DA; Jones LB; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006134. PubMed ID: 17054275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review of the impact of oral contraceptives on cognition.
    Warren AM; Gurvich C; Worsley R; Kulkarni J
    Contraception; 2014 Aug; 90(2):111-6. PubMed ID: 24856205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.